image
Reviva Pharmaceuticals Holdings, Inc. RVPH
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.7456
-4.7 %
$ 34.8 M
Market Cap
-0.83
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
29.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Reviva Pharmaceuticals Holdings, Inc.
image
RVPH has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart RVPH

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RVPH

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)($40.0m)($40.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RVPH

image
$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)2022202220232023202420242025202520262026202720272028202820292029